Biceps Tenodesis Market Size, Share and Trends Analysis - Global - 2023-2029 - MedCore - Includes: Suture Ankles, and 1 more

Biceps Tenodesis Market Size, Share and Trends Analysis - Global - 2023-2029 - MedCore - Includes: Suture Ankles, and 1 more

Overall, the global biceps tenodesis market was valued at $120 million in 2022. This is expected to increase over the forecast period at a CAGR of 4.4% to reach $162.8 million.The full report suite on the global market for biceps tenodesis includes suture anchors and tenodesis screws.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Procedure Volumes
Company Profiles, Product Portfolios and SWOT for Top Competitors
COVID-19 Impact Analysis

PROCEDURE NUMBERS

The biceps can be treated through either tenodesis or tenotomy procedures. Tenodesis involves cutting and reattaching the tendon using a screw or suture anchor, while tenotomy detaches the tendon, resulting in a loss of strength and the characteristic Popeye bulge. While tenotomy is a simpler procedure, repair surgery through tenodesis is generally considered to be more effective. Tenotomy may be performed along with other procedures as needed. The number of biceps tenodesis procedures is expected to moderately increase over time.

GLOBAL BICEPS TENODESIS MARKET TRENDS

Recent clinical evidence suggests that tenodesis is more effective than tenotomy in repairing the biceps tendon. While both procedures offer similar functional outcomes, tenotomy carries a higher risk of causing cosmetic deformity known as the Popeye effect, compared to tenodesis. This has led to a growing preference for using tenodesis devices in bicep tendon repairs, which is expected to drive market growth.

GLOBAL BICEPS TENODESIS MARKET SHARE INSIGHTS

The global biceps tenodesis market is dominated by three main competitors: Arthrex, Smith & Nephew, and DePuy Synthes. Arthrex held the largest share of the global biceps tenodesis repair market in 2022, accounting for more than a third of the total market share. Arthrex offers a range of tenodesis implants under its SwiveLock® brand, which are designed for biceps tenodesis and are available in suture eyelets or closed eyelets configurations.

GLOBAL BICEPS TENODESIS MARKET SEGMENTATION SUMMARY

Suture Anchor Market
Tenodesis Screws Market

RESEARCH SCOPE SUMMARY

Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.